We are live on ! Find out more
APLT

Applied Therapeutics

Delisted

APLT was delisted on the 2nd of February, 2026.

69 hedge funds and large institutions have $319M invested in Applied Therapeutics in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 13

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

15% more capital invested

Capital invested by funds: $278M → $319M (+$40.7M)

3% more funds holding

Funds holding: 6769 (+2)

1.82% more ownership

Funds ownership: 57.11%58.93% (+1.8%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

72% less call options, than puts

Call options by funds: $423K | Put options by funds: $1.53M

Holders
69
Holders Change
+2
Holders Change %
+2.99%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
10
Increased
29
Reduced
13
Closed
8
Calls
$423K
Puts
$1.53M
Net Calls
-$1.1M
Net Calls Change
-$1.42M
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of Montreal
76
Bank of Montreal
Ontario, Canada
-$9K -510 Closed
PHK
77
Point72 Hong Kong
Hong Kong
-$8K -424 Closed

APLT Hedge Fund Activity: Q2 2021 in Review

69 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q2 2021, worth a combined $319M — up 15% from $278M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new APLT positions and 8 closed out — a net gain of 2 holders — while 29 added to existing stakes and 13 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $3.68M. The largest seller was Fidelity Investments, cutting an estimated $2.14M.

  • 69 institutional investors held Applied Therapeutics (APLT) as of Q2 2021, up from 67 in Q1 2021.
  • Funds reported $319M of Applied Therapeutics stock for Q2 2021, up 15% quarter-over-quarter.
  • 10 funds opened new Applied Therapeutics positions in Q2 2021 and 8 closed out, a net change of +2 holders.
  • The largest Applied Therapeutics buyer in Q2 2021 was Point72 Asset Management, an estimated $3.68M added.
  • The largest Applied Therapeutics seller in Q2 2021 was Fidelity Investments, an estimated $2.14M sold.

Based on aggregated 13F filings for Q2 2021.